Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 3,981–4,000 of 17,937 drug recalls

Drug Recall Completed Historical recordClass II

SB-5 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 50 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0024-10

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Lack of assurance of sterility.
Recall initiated
May 9, 2022
Reported by FDA
June 1, 2022
Distribution
Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

View recall →

Drug Recall Completed Historical recordClass II

RE-2 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 300 mcg/mL, Packaged as a) 2.5 mL Multi Dose vial, NDC 73198-0016-03; b) 10 mL Multi Dose vial, NDC 73198-0016-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Lack of assurance of sterility.
Recall initiated
May 9, 2022
Reported by FDA
June 1, 2022
Distribution
Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

View recall →

Drug Recall Completed Historical recordClass II

RE-1 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 200 mcg/mL, packaged as a) 2.5 mL Multi Dose vial, NDC 73198-0015-03; b) 10 mL Multi Dose vial, NDC 73198-0015-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Lack of assurance of sterility.
Recall initiated
May 9, 2022
Reported by FDA
June 1, 2022
Distribution
Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

View recall →

Drug Recall Completed Historical recordClass II

QM-4 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 300 mcg/mL Atropine 0.2 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0020-10

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Lack of assurance of sterility.
Recall initiated
May 9, 2022
Reported by FDA
June 1, 2022
Distribution
Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

View recall →

Drug Recall Terminated Historical recordClass III

Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.

by GlaxoSmithKline LLC

Reason
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
Recall initiated
May 13, 2022
Reported by FDA
June 1, 2022
Distribution
Nationwide in the U.S.

View recall →

Drug Recall Terminated Historical recordClass II

Losartan Pot/HCTZ 100/25 mg 90 Tabs NDC 72189-289-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540

by Direct Rx

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Recall initiated
May 11, 2022
Reported by FDA
June 1, 2022
Distribution
FL

View recall →

Drug Recall Terminated Historical recordClass II

Losartan Pot/HCTZ 50/12.5 mg 90 Tabs NDC 72189-297-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540

by Direct Rx

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Recall initiated
May 11, 2022
Reported by FDA
June 1, 2022
Distribution
FL

View recall →

Drug Recall Terminated Historical recordClass II

Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540

by Direct Rx

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Recall initiated
May 11, 2022
Reported by FDA
June 1, 2022
Distribution
FL

View recall →

Drug Recall Terminated Historical recordClass II

Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5 mg, Pkg Size: 30, NDC: 68788-7758-03.

by Preferred Pharmaceuticals, Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Recall initiated
May 3, 2022
Reported by FDA
June 1, 2022
Distribution
Within the U.S in FL and CA.

View recall →

Drug Recall Terminated Historical recordClass II

Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.

by Preferred Pharmaceuticals, Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Recall initiated
May 3, 2022
Reported by FDA
June 1, 2022
Distribution
Within the U.S in FL and CA.

View recall →

Drug Recall Terminated Historical recordClass III

Higher Education Make Out Ready Vegan Lip Balm, SPF 15, Net Wt. 0.15 oz (4.25 g) per tube, Active Ingredients: Oxtinoxate (7.5%), Oxybenzone (3%); Distributed by: Higher Education Skincare, 1.833.251.0388

by Eco Lips, Inc

Reason
Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product therein is made with Octinoxate 7.5%, Octisalate 5%, Octocrylene 5%, and Avobenzone 3%.
Recall initiated
April 29, 2022
Reported by FDA
June 1, 2022
Distribution
CA

View recall →

Drug Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

by Noven Pharmaceuticals Inc

Reason
Defective Delivery System: customer complaints exceeded respective action limits.
Recall initiated
May 6, 2022
Reported by FDA
June 1, 2022
Distribution
Nationwide to the U.S. Market

View recall →

Drug Recall Terminated Historical recordClass II

Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90

by Direct Rx

Reason
CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Recall initiated
May 13, 2022
Reported by FDA
June 1, 2022
Distribution
Nationwide to the U.S. market

View recall →

Drug Recall Terminated Historical recordClass II

Losartan HCTZ 100/12.5 mg, 90 count bottles NDC# 70518-2564-00 Repackaged NDC Original NDC # 68180-0216-09

by RemedyRePack Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Recall initiated
May 2, 2022
Reported by FDA
June 1, 2022
Distribution
Product was distributed to FL, SC and VA

View recall →

Drug Recall Terminated Historical recordClass II

Losartan HCTZ 100/25 mg, 90 count bottles NDC# 70518-2578-00 Repackaged NDC Original NDC # 68180-0217-09

by RemedyRePack Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Recall initiated
May 2, 2022
Reported by FDA
June 1, 2022
Distribution
Product was distributed to FL, SC and VA

View recall →

Drug Recall Terminated Historical recordClass II

Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00

by RemedyRePack Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Recall initiated
May 4, 2022
Reported by FDA
June 1, 2022
Distribution
Recalled product was distributed to Florida.

View recall →

Drug Recall Completed Historical recordClass II

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

by Cardinal Health Inc.

Reason
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
Recall initiated
April 5, 2022
Reported by FDA
May 25, 2022
Distribution
NM only

View recall →

Drug Recall Completed Historical recordClass II

Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80

by Cardinal Health Inc.

Reason
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Recall initiated
April 5, 2022
Reported by FDA
May 25, 2022
Distribution
NM only

View recall →

Drug Recall Completed Historical recordClass I

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

by Cardinal Health Inc.

Reason
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Recall initiated
April 5, 2022
Reported by FDA
May 25, 2022
Distribution
NM only

View recall →

Drug Recall Terminated Historical recordClass III

Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2

by Apotex Corp.

Reason
Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
Recall initiated
May 3, 2022
Reported by FDA
May 25, 2022
Distribution
Nationwide in the USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.